GSK's drive to resurrect its multiple myeloma therapy Blenrep has continued with new data from the DREAMM-7 trial showing an ...
As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...
DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback